06 February 2011

UBS: Bharat Heavy Electricals Limited - Good defensive, attractive valuations

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Bharat Heavy Electricals Limited 
Good defensive, attractive valuations 
  
„ BHEL has outperformed the BSE Capital Goods Index 10% YTD
With very strong revenue visibility, we continue to maintain that BHEL is a very
good defensive stock in the Indian Capital Goods space. If we look at the stock’s
performance YTD, it outperformed the broader market (BSE Sensex) by 7%. In the
capital goods space as well, BHEL is one of the best performing stocks and has
outperformed the BSE Capital Goods Index 10% YTD.
„ Q3 FY11 results were ahead of consensus
In Q3 FY11, revenues grew 19% YoY to Rs85.8bn. EBITDA margins expanded
150bps YoY to 23.1% (consensus at 20%) and PAT was up 25% YoY to Rs13.4bn
(consensus at Rs12.9bn). At the end of Q3 FY11, the order book stands at
Rs1.58trn, up 10% versus the FY10 order book. Overall, Q3 results were ahead of
consensus estimates.
„ Valuations are attractive for BHEL
BHEL is currently trading very close to the lower end of its trading range (at <15x,
1-year forward earnings). We think that with significant expansion in
manufacturing capacity, BHEL may continue to benefit from operating leverage.
This, combined with strong corporate governance standards and reasonably
encouraging news flow, makes current valuations very attractive in our view.
„ Valuation: maintain Buy, PT of Rs2,950; top pick in capital goods space
We base our price target of Rs2,950 on our DCF valuation. Our key assumptions
are a WACC of 11.9%, a medium-term growth rate of 15%, and 5% long-term
growth. BHEL is our top pick in the capital goods space.


Attractive valuations
BHEL is currently trading at <15x 1-year forward earnings. We believe with
significant expansion in manufacturing capacity, it may continue to benefit from
operating leverage. This, combined with strong corporate governance standards
and reasonably encouraging news flow, makes current valuations appear very
attractive in our view.


Q3 results were ahead of consensus
In Q3 FY11, operating income grew 19% YoY to Rs85.8bn. EBITDA margins
expanded 150bps and recurring PAT was up 25% YoY to Rs13.4bn. The results
were ahead of consensus (PAT expectation of Rs12.9bn). At the end of Q3
FY11, the order book stands at Rs1.58trn, up 10% versus the FY10 order book.


We remain positive on the stock and maintain BHEL as our top pick in the India
Capital Goods space.





Q Bharat Heavy Electricals Limited
Bharat Heavy Electricals (BHEL) focuses on the Indian power equipment
business. Its main customers are National Thermal Power Corporation (NTPC)
and state electricity boards that account for over 70% of revenue. BHEL also
services the power transmission, captive power plant, industrial equipment, and
the transport segments. It is 68%-owned by the Government of India.
Q Statement of Risk
The key risks for BHEL remain execution, delivery, raw material costs, and
order inflows.



Kotak Sec:: Buy Bank of Baroda- Focus on consistency and quality maintained.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Bank of Baroda (BOB)
Banks/Financial Institutions
Focus on consistency and quality maintained. Bank of Baroda delivered yet another
quarter of impeccable earnings, driven by steady loan growth (up 33%), strong deposit
growth (31% yoy), improving margins (up 18 bps qoq) and contained asset quality
(delinquency at 0.6% for 3Q). Credit/deposit ratio at 71% is amongst the best in the
industry and will support strong growth. A focused management continues to deliver
consistent growth, sustaining RoAs at 1.3% and RoEs at 22-24%. Stock trades at 1.5X
FY2012E PBR. Retain BUY.

UBS: Sell Cipla -Q3FY11: Missing again on cost & currency

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Cipla Ltd. 
Q3FY11: Missing again on cost & currency 
 
„ Sales Q3FY11: Rs 15.0bn (+12%YoY); EBITDA: Rs 3.2bn (-21%YoY)
India/Export revenues grew 11%/12%YoY respectively. However, revenues were
down 5%qoq partly due to 4%qoq USD depreciation vs INR which impacted
margins. EBITDA declined 21%YoY due to lower technology fees and higher staff
cost (+52%YoY) and other expenses (+26%YoY). Other expenses grew 12% qoq,
we believe primarily due to higher selling expenses. Net profit declined 19% YoY
to Rs 2.32bn (-12%qoq). We reduce our FY11/12 earnings by 9%/6% due to lower
than expected revenues and margins ytd.

JP Morgan: Buy GSK Consumer Healthcare- Taller, Stronger and Sharper

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Glaxosmithkline Consumer Healthcare Limited 
Initiation ; Overweight ; GLSM.BO, SKB IN 
Taller, Stronger and Sharper



• We initiate with an Overweight rating and a Dec-11 price target of
Rs2580,  based on 1.5x PEG, in line with local peers (equivalent to 29x
CY11E and 25x CY12E EPS). Our PT implies potential upside of 23% from
current levels. GSK Consumer is the market leader in India’s malted food
drinks category with over 70% share, and enjoys strong brand equity with a
pan-India distribution network. It benefits from astute marketing and
innovation, which in our view should continue to support market share
gains and mix enhancements. We expect improving margins, strong free
cashflow and potentially higher dividend payout to support price
performance.

UBS: Nagarjuna -Misses estimates led by lower execution

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Nagarjuna Construction Company 
Misses estimates led by lower execution 
 
„ Q3 revenues up 13% YoY, with EBITDA margins of 9.6%
Nagarjuna reported Q3 revenues (standalone) of Rs13.4bn (+13% y/y, UBS-e
Rs14.1bn), EBITDA margins of 9.6% (-40bps y/y, UBS-e 10%) and PAT of
Rs404m (UBS-e Rs515m). Adjusted for additional tax provision of Rs40m, PAT
would be Rs444m. 9mFY11 revenues are at Rs36bn (+11% y/y) with EBITDA
margins of 9.8% (-30bps y/y) and PAT of Rs1.3bn (-2% y/y; this is after additional
tax provision of Rs80m related to IT enquiries; another Rs70m likely in Q4).

Sun Pharmaceuticals: One-offs affect 3Q, growth intact with several triggers: Kotak Sec

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Sun Pharmaceuticals (SUNP)
Pharmaceuticals
One-offs affect 3Q, growth intact with several triggers. PAT at Rs2.2 bn was 16%
lower than our est. due to (1) lower EBITDA margin with one-offs in staff costs, other
expenses, and (2) one-offs in depreciation, tax on account of Taro. Adjusting for the
one-offs, we believe EBITDA margin is at 33%, 300 bps higher than our est. FY2011E
sales guidance of 42% implies some of these adjustments may reoccur in 4QFY11E. We
leave our FY2011-12E est. largely intact and include mid-FY2012E Taxotere launch.
Several triggers exist which are likely to result in meaningful upside to our FY2012E EPS.
We move rating a notch lower to ADD (from BUY) with PT intact at Rs480.

Kotak Sec:: Siemens- Strong results but aided by low base and unreliable margins.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Siemens (SIEM)
Industrials
Strong results but aided by low base and unreliable margins. Revenues of Rs25
bn, 12% ahead of estimates, were led by power on pick-up of execution of large orders
and favourable base. Industrials segment remained relatively moderate - likely reflection
of weak capex cycle. Inflows of Rs40 bn, though strong (led by Torrent order-execution
unlikely in near term), were significantly lower than indication from global results (of
Rs70 bn). Retain REDUCE on valuations as base effect wears off and margins normalize.

Kotak Sec : Buy Jaiprakash Associates - Real estate shines.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Jaiprakash Associates (JPA)
Others
Real estate shines. Jaiprakash Associates reported better-than-estimated results, with
the real estate segment compensating for weak realizations in the cement business and
moderation of construction revenues. The cement segment reported 31% yoy growth
in volumes, well ahead of the industry growth rate of 5.5%. We remain optimistic
about the growth prospects of JAL given the pace of execution across business
segments and reiterate our BUY rating with a revised target price of Rs135/share.

BofA Merrill Lynch:: Buy Voltas -Banking stronger summer season AC sales recovery

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Voltas  -Banking stronger summer season AC sales recovery 

„Maintain Buy on AC sales & Mid East recovery, PO down 19%
Voltas recurring net profit at Rs534mn declined 20% y-o-y and is 30% below
estimate. Loss in the electrical construction project being executed by subsidiary
company Rohini and inventory correction in room AC led to earning miss. We
have cut earnings and hence PO by 19% to Rs220. We have maintained Buy as
we expect growth in earnings to recover from Q4FY11 driven by stronger summer
season AC sales and rise in Middle East project revenue.

BofA ML: Buy Cummins India -Value in slower but sustainable growth

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Cummins India -Value in slower but sustainable growth 

„Maintain Buy on sustainability of 18% growth; PO down 16%
Cummins India Q3FY11 PAT declined 6% and missed our estimate by 21%.
Slower genset sales owing to slower infra growth and lesser working days owing
to 10 days plant shutdown led to earning miss.  We have cut earnings and hence
PO by 16% to Rs760. We have maintained a Buy as we expect the company to
sustain 18%+ profit growth owing to exports and commencement of old engine
rebuild center. At our PO of Rs760 the stock would trade at 20x FY12e adjusted
for Rs40/sh as the value of its investment in several JV companies.

Goldman Sachs: Buy Nagarjuna -positive surprise on inflows

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Nagarjuna Construction Company (NGCN.BO) 
Buy  Equity Research
Below expectations on revenue, positive surprise on inflows; Buy 
What surprised us
Nagarjuna Construction announced 3QFY11 revenue of Rs13.4 bn, below
our and Bloomberg consensus estimates. Net profit for the quarter of
Rs404 mn was also below our and consensus estimates mainly on account
of increased interest expenses. However, order inflow was strong at Rs27
bn vs. Rs35 bn in 1HFY2011. As a result, its order book as of December end
stood at Rs173 bn (7% growth qoq and 17% yoy). The order inflow for the
quarter does not include any in-house BOT orders for the company.

Morgan Stanley: India Strategy: QE Dec-10 Earnings Season Thus Far

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India Strategy
Quick Comment: QE Dec-10 Earnings Season Thus Far


Revenue and earnings growth remain strong for the MS coverage  •
universe at 22% YoY. Aggregate earnings for MS coverage
companies are ahead of MS analysts’ expectations by 6ppt.
Ex-Energy, MS coverage earnings growth was at 12% YoY (i.e.,  •
4ppt ahead of MS analysts’ expectations).
ed an aggregate of  of them) have report Sensex companies (22  •
24% growth in earnings – ahead of expectations.
Around 63% of the companies (50 out of the 80 companies) have  •
beaten MS analyst expectations.
Eight out of the 10 sectors saw more earnings beats than misses. •
More than four-fifths of the companies (19 out of 23 companies) in  •
the Financials sector have beaten MS analysts’ expectations while
two-thirds of the companies in Consumer Discretionary space have
missed.
Margin compression in eight out of 10 sectors. The exceptions are  •
Financials and Energy.
1,446 companies in the broader market have reported earnings  •
growth (of 23% YoY) more or less in line with the narrow market.
Please see slide 3 for a granular breakdown of earnings by market cap
quintile.



JPMorgan:: Sterlite Industries- Completes second zinc mine acquisition

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Sterlite Industries 
Overweight; STRL.BO, STLT IN
STLT completes second zinc mine acquisition; On track for completion of the transaction


• Sterlite completes acquisition of Anglo's second zinc asset-Black
Mountain Mine: Sterlite acquired 74% interest in the Black Mountain
Mine in South Africa from Anglo American for a total consideration of
$348MM, which includes replacing the shareholder loan of $88MM.
The remaining 26% of the mine is  held by Exxaro. This acquisition
includes the Black Mountain zinc mine (attributable R&R of 51.7MT;
2009 attributable Zn prodn of 21kt and Pb prodn of 36kt) and the
Gamsberg zinc project (undeveloped Zn mine with R&R of 137.6MT).
This, along with the Skorpion mine (R&R of 8.3MT; 2009 prodn of
150kt) acquisition completed in Dec-10, is part of the proposed
acquisition of Anglo's three zinc assets announced in May-10 for
$1.338bn. The third asset is the Lisheen zinc mine in Ireland (R&R of
8.7MT; 2009 prodn of 191kt), which we believe should be completed
over the next few months.

Sell Cipla -3Q below expectations; margins compress; Goldman Sachs

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


COMMENT
Cipla (CIPL.BO) Rs324.20
   Equity Research
First Take: 3Q below expectations; margins compress; maintain Sell
News
Cipla reported 3QFY11 net income of Rs2.3bn which was 17%/18% below
GS/Bloomberg estimates. Revenue of Rs15.5bn was 3%/2% below
GS/Bloomberg estimates mainly due to sluggish domestic revenue growth
of 8% (yoy). EBIT margins compressed by 700 bp yoy to 16.3% on the back
of increased costs from the recently commissioned Indore SEZ plant.

JP Morgan: Oil India - 3QFY11 impacted by lower offtake/higher dry well expenses

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Oil India Ltd. 
Underweight
OILI.BO, OINL IN
3QFY11 impacted by lower offtake/higher dry well expenses 


• 3Q profits below expectations:  Oil India reported 3Q profits of
Rs9.08bn (down 1% q/q), below expectations, led by a combination of
higher dry well expenses, higher subsidies and lower than expected
crude oil production.

JP Morgan: Hero Honda- 3QFY11 PAT of Rs.4.3B down 20% yoy

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Hero Honda
Underweight
HROH.BO, HH IN
3QFY11 PAT of Rs.4.3B down 20% yoy on lower operating margins and provisioning costs


• Hero Honda’s 3Q reported PAT at Rs.4.3B (-20% yoy) was significantly
below our and street estimates. The variance was driven by weak margins as
well as provisioning charges. EBITDA margins came in at 11.2% (-610bp yoy
and -220bp qoq) given rising input costs and higher ad spends. Further,
provisioning costs (of Rs.798m) relate to National Calamity Contingency Duty
(NCCD) claims for FY09-10. We reiterate our UW stance on the company
given rising competitive intensity and margin pressures.

Morgan Stanley: Buy Cox & Kings F3Q11: In-line Results; target Rs660.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Cox & Kings Ltd  
F3Q11: In-line Results; Cash 
Continues to Affect Earnings 
Quick Comment – Strong revenue growth, margin
affected by phasing of ad spending: Cox & Kings
reported revenue, operating profit, and PAT growth of
37%, 27%, and 6%, respectively vs. our expectations of
28%, 28%, and 6%. The strong revenue growth was
broad-based with both domestic and international
operations performing well. The key highlights of the
result are: 1) higher advertisement expenses; 2) lower-
than-expected financial income; and 3) high levels of
cash continue to depress return ratios for the company.

Deutsche Bank: Buy Oil India - 3Q results in line with estimate

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Oil India Limited- Buy
3Q results in line with estimate; net oil realisation up QoQ

 Oil India reports INR9.1bn net profit; in line with estimates
Oil India (OIL) reported net profit at INR9.1bn (+27% YoY and -1% QoQ)
and EBITDA at INR13.1bn (+19% YoY, -6% QoQ), in line with estimates. As
expected, net crude realization at US$67.1/bbl (+14% YoY, +6% QoQ) was
sequentially higher because of higher crude oil prices. This validates our
view that post petrol price deregulation, Oil India has a marginal positive
impact from rising oil prices. OIL's subsidy contribution increased in the
quarter to INR5.6bn (+20% YoY, +40% QoQ). Oil production at 0.93mn te
(+1.9% yoy, -0.5% qoq) and gas production at 0.62bcm (-1.6% yoy, +5.7%
qoq) was also in line with estimates.

Buy Balrampur Chini, Dec 10 Qtr: Sugar Shines- target Rs129: Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Balrampur Chini Mills  
Dec 10 Qtr: Sugar Shines, Cogen & Distillery Disappoint 
Sugar Profitability Returns: BRCM reported
December quarter results with revenues, EBITDA and
PAT of Rs5.3bn, Rs724mn and Rs234mn.
Key highlights of the results: 1) Sugar division reporting
profits (Rs250mn) as against a loss in the previous
quarter (Rs540mn), 2) Realizations for sugar division
were down 10% YoY and 3) Unlike in Dec’10 quarter,
where BRCM had benefitted from carrying low cost
inventory, this time around BRCM has carried high cost
inventory in Q1. We do not expect cane prices to be bid
up this season and this combined with a tight domestic
sugar balance drives our OW rating on the stock.

JP Morgan: Buy Suzlon Energy- Another loss making quarter:: target Rs 64

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Suzlon Energy Ltd
Overweight
SUZL.BO, SUEL IN
Another loss making quarter, weak sales realization per MW a concern


• Weak Dec-q: Adjusted loss of Rs1.9B at consolidated level in Dec-q was
well below our est. of ~Rs0.98B profit and consensus est. of Rs1.26B loss.
The disappointment was led by- (A) 12.2% dip in sales realization per
MW to Rs54.4mn in Suzlon’s wind business. Dec-q sales volume of
461MW was slightly ahead of our 450MW est., but EBITDA margin
improvement to 6.9% lagged est. by 60bps, (B) Weak operating results in
REPower:  The subsidiary reported EBITDA of just Rs90MM vs. our
expectation Rs2.28B for Dec-q. The  cost pressure was led by higher
RM/sales. REPower has reported PAT loss of Rs820MM in Dec-q and
9MFY11 loss of Rs2.43B.

UBS: Buy IBN18 Broadcast - Management meeting takeaways; target Rs130;

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
IBN18 Broadcast 
Management meeting takeaways 
 
„ Takeaways from meeting with Haresh Chawla (Group CEO, Network18)
1) The distribution partnership with Sun (Sun18) is likely to start contributing to
subscription revenue growth from 1QFY12. 2) IBN18 management plans to
increase the number of hours of original content in its Hindi general entertainment
channel (GEC), ‘Colors’. It currently has ~24 hours/week of original content. 3)
IBN18 plans to launch a few regional entertainment channels in FY12. 4) IBN18
plans to produce or co-produce 6-7 movies in FY12, which is likely to contribute
~10% to Viacom18’s revenue.

UBS: Replacing Bharti with Idea as a most preferred

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
UBS Global Telecommunications
Changes to our most and least preferreds

„ Adding Bezeq to our most preferred list
Bezeq has pulled back c.8% from its highs in recent days, partly due to concern
around events unfolding in the Middle East. We see earnings upside from the
renewed Union deals, network efficiencies from the move to fibre, and expect the
mobile market to stay rational despite recent MTR cuts. The announcement of a
series of special dividends provides for a 13-14% annual cash return.

Replacing Bharti with Idea as a most preferred 
We remain positive on the Indian market, due to stabilising price competition, a
more visible regulatory outlook given the new Minister of Telecoms, and prospects
for consolidation. We have changed our exposure from Bharti to Idea for pure play
exposure to India. Also, Idea could be a consolidation candidate, in our view.

Accumulate Lakshmi Machine Works – 3QFY2011 Result Update:: Angel Broking-

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


 Lakshmi Machine Works  – 3QFY2011 Result Update

          Angel Broking upgrades Lakshmi Machine Works to Buy from Accumulate with a Target Price of Rs. 2,891.

For 3QFY2011, Lakshmi Machine Works (LMW) reported top-line growth of
49.7% yoy to `491cr (`328cr), which was 2.8% below our estimates of `505cr.
OPM fell by 141bp to 15.4% (16.8%), which was below our estimates of 16.5%.
On account of strong top-line growth , PAT grew by robust 50.2% yoy to `46cr
(`31cr). For FY2011 and FY2012, we have revised our top-line estimates
marginally downwards by 1.1% and 1.4% to `1,863cr and `2,453cr, respectively,
and PAT estimates by 1.5% and 2.9% to `156cr and `223cr, respectively. Owing
to the correction in the stock price, we upgrade the stock to Buy (Accumulate) with
a revised Target Price of `2,891/share.

Kotak Sec:: Add Lupin- Lower-than-expected results, FY2012E outlook intact.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Lupin (LPC)
Pharmaceuticals
Lower-than-expected results, FY2012E outlook intact. PAT at Rs2.2 bn was lower
than our est. by 12% for underperformance in US branded biz with India/Japan sales in
line and lower EBITDA margin. We reduce FY2011-12E est. by 10-8% for (1) lower US
branded sales and (2) lower margin assumptions. However, with US generic biz outlook
intact, we estimate 27% EPS growth in FY2012E. We value Lupin at (1) 20X FY12E core
EPS, (2) DCF value of Rs9/share from settled exclusivities. ADD; PT Rs465 (was Rs490).

Kotak Sec : Sun TV Network :Endhiraan shines; some clouds over core business.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Sun TV Network (SUNTV)
Media
Endhiraan shines; some clouds over core business. Sun TV reported 3QFY11 EBIT at
Rs3.28 bn (+46% yoy, +36% qoq) led by (1) blockbuster movie ‘Endhiraan’ EBIT
contribution of Rs440 mn and (2) lower-than-expected amortization of telecast rights.
However, 3QFY11 advertising and subscription revenues were below expectations;
advertising growth has tapered off despite seasonally strong quarter and steady ratings
performance. Retain our estimates for now; we await management commentary on
3QFY11 operating metrics. Sun TV also declared an interim dividend of Rs5/share,
already implying FY2011E dividend yield of 2.1%.

Buy Mahindra & Mahindra Jan’11 – Robust performance across segments; Anand Rathi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Mahindra & Mahindra
Jan’11 – Robust performance across segments; Buy
M&M’s Jan’11 volume growth was above expectations, at 21.7%
yoy (and 13.5% mom) to 57,217 units. Growth in all segments
was strong.

Glenmark Pharmaceuticals: Strong Buy; Target : Rs 396:: ICICI Securities

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Glenmark Pharmaceuticals - US generics to hold the key…
Glenmark Pharmaceuticals’ Q3FY11 numbers were in line with our
expectation. The sales grew 17% YoY to | 750.8 crore in line with our
expectation of  | 740 crore driven by strong growth in the domestic
formulation and Latin America business (speciality business). EBITDA
margins witnessed de-growth of 330  bps YoY to 23.2% due to lower
realisation (appreciation of rupee). Thanks to forex gain of  | 18 crore,
net profit grew 16% to | 109.5 crore. With US generics expected to get
momentum in due course, we maintain our STRONG BUY rating.

Buy Federal Bank – 3QFY2011 Result; Target Rs. 436:: Angel Broking

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Federal Bank – 3QFY2011 Result Update

Angel Broking maintains a Buy on Federal Bank with a Target Price of Rs. 436.

For 3QFY2011, Federal Bank recorded net profit growth of 29.8% yoy and 1.9%
qoq to `143cr, in line with our estimates. NII grew by 17.4% yoy and 2.0% qoq to
`447cr. Subdued business growth and continued setbacks in asset quality were
the key highlights of the results. We maintain Buy on the stock.

Kotak Sec: Crompton Greaves: In-line results; BUY as diversified presence buffers risks.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Crompton Greaves (CRG)
Industrials
In-line results; domestic power sedate; BUY as diversified presence buffers risks.
Crompton reported in-line results at the revenue and margin front. PAT of Rs2.3 bn was
10% ahead of estimates due to lower-than-expected tax rate. Power segment remained
sedate (flat yoy revenues) in 9M, while industrials and consumer grew strongly.
Reiterate BUY on diversified business (across segments and geographies), overseas
business recovery, strong execution and balance sheet.

Kotak Sec: Oriental Bank of Commerce (OBC) Weak franchise resulting in margin pressures

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Oriental Bank of Commerce (OBC)
Banks/Financial Institutions
Weak franchise resulting in margin pressures. OBC reported weak 3Q numbers, as
margins declined (20 bps) owing to its weaker liability franchise and higher reliance on
wholesale deposits. While we expect this trend to continue, the management is taking
prudent measures to slow down growth and is guiding for stable margins (we assume it
decline further by 25 bps). NPL increase during the quarter was unexpected, but this
tends to be lumpy in nature. Margin concerns notwithstanding, we retain ADD rating
owing to its attractive valuations at 0.8X FY2012E PBR. Revise TP to `450.

Maruti Suzuki - Jan’11 volume: Good show, in line with expectations: Anand Rathi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Maruti Suzuki India
Jan’11 volume: Good show, in line with expectations
In Jan ’11, Maruti Suzuki posted stable volume growth of 14.7%
yoy (and 10.6% mom) to 109,743 units, in line with expectations.
Volumes followed the normal January trend, being better mom.

Sun Pharmaceutical- Mixed quarter, maintain Hold: Anand Rathi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Sun Pharmaceutical Industries
Mixed quarter, maintain Hold
Sun Pharma’s (Sun) 3QFY11 results were a mixed bag, with
revenue being higher and PAT lower than our estimates. While
revenue grew 56.8% yoy to `16bn, adjusted PAT grew only 8.4%
yoy to `3.7bn due to 860bps decline in EBITDA margin.

Sarda Energy and Minerals– 3QFY2011 Result Update Angel Broking maintains a Buy on Sarda Energy and Minerals with a Target Price of Rs. 294.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Sarda Energy and Minerals– 3QFY2011 Result Update

Angel Broking maintains a Buy on Sarda Energy and Minerals with a Target Price of Rs. 294.


Sarda Energy and Minerals (SEML) reported disappointing set of numbers for
3QFY2011. While net sales increased 38.9% yoy to `214cr, adjusted net profit
declined by 59.7% yoy to `5cr. We remain positive on SEML and recommend a
Buy on the stock.

Angel Broking maintains a Neutral on Hero Honda.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


 Hero Honda  – 3QFY2011 Result Update

Angel Broking maintains a Neutral on Hero Honda.


Hero Honda (HH) reported a mixed performance during 3QFY2011, with
better-than-expected top-line growth, driven by robust volume growth; however,
adjusted net profit came in lower than our estimates, largely due to subdued
performance on the operating front on account of raw-material cost pressures.
We revise our earnings estimates marginally downwards due to lower-thanexpected
performance on the operating front and remain Neutral on the stock.

Kotak Sec: Buy Oberoi Realty - Good quarter, best-placed in challenging times.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Oberoi Realty (OBER)
Property
Good quarter, best-placed in challenging times. Oberoi reported revenues and net
profit 14% and 8% above our expectation. We find Oberoi better-placed given its
debt-free status and lower risk of regulatory-led delays but we reduce sales estimates by
14% for FY2012E and FY2013E as we account for a period of slower sales. We
reiterate our BUY recommendation with a reduced target price of Rs305/share on
higher cost of capital assumption.

Kotak Sec: Bharat Electronics: In-line results; but concerns on dip in contribution margin, high 4Q asking rate

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� �


Bharat Electronics (BHE)
Industrials
In-line results; but concerns on dip in contribution margin, high 4Q asking rate.
Bharat Electronics reported revenues of Rs13.3 bn, 9.8% above estimates and up
10.7% yoy. EBITDA margin at 16.2% (in-line) was significantly below 3QFY10 margin
primarily led by higher raw material cost as percentage of sales. Net PAT at Rs1.7 bn
was broadly in line with our estimates. We highlight potential risk to full-year estimates
and MOU target for ‘excellent’ rating which implies a strong asking rate for 4QFY11E.

Great Offshore: Buy Target : Rs 343:: ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Great Offshore -Performance to improve in FY12…
Great Offshore Ltd (Great Offshore) reported disappointing results in
Q3FY11 with its topline declining 18% YoY while net profit registered a
decline of 96%. Lower fleet utilisation was the main contributor to the
decline in topline with drilling rigs and construction vessels utilisation
at 43% in Q3FY11 against 100% in Q3FY10. Going forward, we expect
revenues in FY11 to decline by 7% to  | 1081.2 crore but expect 23%
revenue growth in FY12 as utilisation levels of its drilling rigs increases.
Two of its assets (jack-up rig Kedarnath and drill barge Badrinath) have
secured long-term charters for five and three years, respectively,
providing substantial revenue visibility as they would be operating at
100% utilisation levels in FY12.

Buy Tata Motors Jan’11 volumes: CV base effect in play, UVs, exports impress; Anand Rathi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Tata Motors
Jan’11 volumes: CV base effect in play, UVs, exports impress; Buy

For Jan ’10, Tata Motors reported good volume growth of 15.2%
yoy (and 11.8% mom) to 75,423 units, in line with expectations.
While domestic volumes grew 13.3% yoy, export growth was a
strong 51% yoy.

Maruti Suzuki - Margin bottoms, valuations attractive; upgrade to Buy: Anand Rathi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Maruti Suzuki India
Margin bottoms, valuations attractive; upgrade to Buy
While Maruti Suzuki India’s (MSIL) 3Q results were
unimpressive, as expected, we believe the outlook is better
hereon. Also, at current market price, valuations are attractive.
We upgrade MSIL to Buy from Sell and trim our estimates.

Kotak Sec: Add Titan - Shining beacon. ; TP of Rs4,100

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Titan Industries (TTAN)
Retail
Shining beacon. Amidst an earnings miss season in consumer products, TTAN beat
estimates handsomely. Positive surprises are (1) watches sales growth of 35% (aided by
late Diwali), (2) jewelry volumes growth of 25% (inflation in gold prices makes
diamonds relatively cheaper for the consumer) and (3) negative working capital in
jewelry. Inflation in gold is a tailwind for Titan as (1) it improves absolute EPS and (2)
every 10% increase in gold price raises Titan's jewelry margins by 50 bps. Key risk—any
potential government regulation to curb probable money laundering through gold.

DLF - Weak launches but still a good launch pad :: Kotak Securities

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


DLF (DLFU)
Property
Weak launches but still a good launch pad. DLF has (1) a relatively wide
geographical spread, (2) lower regulatory risk versus Mumbai firms, (3) no share pledges
and (4) a substantial non-residential portfolio which is seeing signs of volume uptick
and has lesser pricing risk due to lack of a run-up. Key negatives include (1) continuing
weak sales and (2) debt increase qoq. We retain ADD with a target price of Rs265/share
(earlier Rs375) with a WACC of 15% and cap. rate of 11% (both increased 100 bps).

Kotak Sec: Buy Indian Overseas Bank (IOB) - Perfect quarter on all fronts.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Indian Overseas Bank (IOB)
Banks/Financial Institutions
Perfect quarter on all fronts. IOB had one of its best quarters ever with considerable
improvement witnessed over all fronts (1) margins expanded by 25 bps qoq to 3.25%
on the back of declining costs, (2) asset quality improved sharply on the back of lower
slippages (less than 1%) and higher recoveries, and (3) loan growth was higher than
industry at 14% qoq. IOB looks to have entered into a strong positive cycle of loan
growth and declining provisions resulting in higher earnings growth. Valuations at 0.8X
FY2012E PBR and 5X PER remain attractive for RoEs of 16%. BUY.

Add Hotel Leela:Higher interest costs dent net margins… ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Hotel Leela -Higher interest costs dent net margins… 
Hotel Leela’s net sales remained in  line with our estimates. It grew
11.4% YoY to | 142.3 crore, backed by a revival in demand especially in
leisure destinations. On the other hand, the operating cost continued to
remain higher and increased by 13.5% YoY on a sharp increase in other
operating costs (i.e. 45% of total  operating cost) that increased 23%
YoY. There has also been a sharp rise in interest costs, which increased
from | 7.6 crore last year to  | 20.1 crore in Q3FY11. Consequently, its
net profit declined by 23.6% YoY.

Automobiles India - No signs of slowdown as yet:: Kotak Sec

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Automobiles India
No signs of slowdown as yet. January auto sales were ahead of our expectations
except for Maruti Suzuki. Key highlights were – (1) Hero Honda corrected some
inventory build-up during the month, in our view, (2) Maruti export volumes
disappointed because of slowdown in European exports, (3) Mahindra tractor volumes
continue to surprise positively and (4) commercial vehicle volumes have softened a bit
mom. We see upside risk to our volume estimates for Mahindra & Mahindra.

Buy YES Bank- report by Motilal Oswal

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Yes Bank began operations in May 2004. Its promoters, who established Rabo India Finance
as a leading investment bank in India, have the distinction of obtaining RBI's only Greenfield
banking license in the past decade. Yes Bank has built a strong management team, with the
leaders of each of its business units being picked from reputed foreign banks. It is now a
"full service" commercial bank with 171 branches and a balance sheet of Rs518b. It aims to
scale up its branch network to 250, with a CASA ratio of ~25% by FY12 (currently 10.1%).

52-WEEK BLOCKBUSTER: Steel Strips Wheels - Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


52-WEEK BLOCKBUSTER: Steel Strips Wheels

Parvatha Vardhini C
Steel Strips Wheels, which manufactures wheel rims for automobiles, has a market share of about 15 per cent in the passenger car segment and over 70 per cent in the two-wheelers segment. Riding on the auto boom since late 2009, the stock has returned 167 per cent over the last year. Thanks to the growing demand, the company has expanded its existing supplies to the margin accretive tractors and commercial vehicles segment. It is increasing capacity at its Chennai plant and has commissioned a unit at Jamshedpur for supplying to LCVs/HCVs from Tata Motors.
During this one year period, the company has also won export orders, the latest being an order worth $9 million for Peugeot's plants in Europe. It has also won business from BMW and Audi last year and is catering to Renault in Brazil and Russia. The company has commenced sales to the after-markets in Europe, where pricing power is better than in sale to OEMs. It has recently sold a 5.88 per cent stake to Sumitomo Metal Industries of Japan at Rs 520 per share. This tie-up will help them develop high tensile steel wheels which would improve fuel efficiency by reducing wheel weight.

GVK Power & Infrastructure - Regulatory hurdles clip GVK’s wings: Kotak Sec

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


GVK Power & Infrastructure (GVKP)
Infrastructure
Regulatory hurdles clip GVK’s wings. Recent AERA orders appear unfavorable for
airport developers: (1) Favors single till model, (2) argues for passing real estate benefit
to airport users and (3) argues against higher RoE. These policies and low visibility on
real estate monetization may adversely impact potential PE investment in airport
vertical. BIAL investment implies valn of 10X P/B; regulatory stance may lead to
downside of Rs4-5/share. Cut TP but retain BUY on cheap valn post sharp correction.

Nalco’s 3QFY11 EBITDA and net income was lower than our estimate: Kotak Sec

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


National Aluminium Co (300)
Metals & Mining
Another miss. Nalco’s 3QFY11 EBITDA of Rs4.1 bn (+25%) and net income of Rs2.56
bn (+65%) was 32% and 35% lower than our estimate. Commissioning of new
alumina refinery has been delayed further by 3 months reflecting weak execution. We
increase our earnings estimates by 7.6% and 1.8% for FY2012E and FY2013E on the
back of our recent revision in aluminium price forecast. We raise our 12-month target
price to Rs300 (Rs285 earlier) but maintain our SELL rating on expensive valuations.